Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Pathway Genomics' Hereditary Colorectal Test; Courtagen's Epilepsy Test

Premium

Pathway Genomics has launched Hereditary Colorectal Cancer DNA Insight, which uses next-generation sequencing to identify genetic alterations that are indicative of a risk for colorectal cancer, including genes related to Lynch syndrome, familial adenomatous polyposis, Li-Fraumeni syndrome, juvenile polyposis, MUTYH-associated polyposis, Peutz-Jeghers syndrome, hereditary diffuse gastric cancer, and PTEN-hamartoma tumor syndrome.


Courtagen Life Sciences has expanded EpiSeek, its next-generation sequencing test for epilepsy and seizure disorders, to include 489 genes associated with seizure disorders. Additionally, the company has also launched an Infancy and Childhood Epilepsy Panel, which targets 70 genes.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.